Showing results (1-10 of 333) with videos related to
Sort By:
Pageof 34
Expert Review of Hematology|November 1, 2016
Diagnosis and management of factor V LeidenElena Campello, Luca Spiezia, Paolo SimioniHepatology (Baltimore, Md.)|February 24, 2023
The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive reviewAlberto Zanetto, Elena Campello, Marco Senzolo, et al.Frontiers in Pharmacology|June 6, 2022
Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the LiteratureAriela Hoxha, Daniela Tormene, Elena Campello, et al.Expert Review of Hematology|February 19, 2019
Thrombophilia, risk factors and preventionElena Campello, Luca Spiezia, Angelo Adamo, et al.Journal of Clinical Medicine|November 11, 2022
Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic DisordersElena Campello, Paolo Simioni, Paolo Prandoni, et al.Seminars in Thrombosis and Hemostasis|January 5, 2024
Venous Thromboembolism in Children: The Rivaroxaban ExperienceLuca Spiezia, Elena Campello, Daniela Tormene, et al.Expert Review of Hematology|November 29, 2023
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infectionAndrea Boccatonda, Elena Campello, Chiara Simion, et al.Biomarkers in Medicine|June 25, 2016
Microparticles as biomarkers of venous thromboembolic eventsElena Campello, Luca Spiezia, Claudia M Radu, et al.Clinical Chemistry and Laboratory Medicine|November 7, 2016
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?Elena Campello, Claudia M Radu, Luca Spiezia, et al.British Journal of Cancer|July 23, 2019
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issuesElena Campello, Anton Ilich, Paolo Simioni, et al.Pageof 34